Popular Articles

First National Survey Seeking NHS Staff Views On Improvement And Innovation Launches This Week
The NHS Institute for Innovation and Improvement launches its first National Innovation and Improvement Survey. Created in partnership with strategic health authorities, the survey offers all NHS staff in the UK an opportunity to influence the national innovation agenda.
drugs without prescription
Can Omega 3 Fatty Acids Prevent Depression In Coronary Heart Disease?
Depression is an established risk factor for the development of coronary heart disease (CHD) in healthy patients and for adverse cardiovascular outcomes in patients with existing CHD. Dietary factors resulting in lower levels of omega 3 fatty acids not only increase CHD risk, but may also be involved in the pathophysiology of depression. The investigators measured red blood cell levels of two omega 3 fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), and assessed depressive symptoms in a cross-sectional study of 987 adults with CHD. Omega 3 fatty acids were blindly measured in fasting venous blood samples using capillary gas chromatography to measure the fatty acid composition of red blood cell membranes. Red blood cell levels of EPA and DHA are presented as a percentage composition of total fatty acid methyl esters. The investigators assessed current depression using the 9-item Patient Health Questionnaire. They evaluated the association between omega 3 fatty acid levels and depressive symptoms as continuous variables using linear regression.
News of the day
New Drug Targeting Cancer Weakness Shows Great Promise
Scientists at The Institute of Cancer Research (ICR) and The Royal Marsden Hospital, working with pharmaceutical company AstraZeneca, have completed a Phase I clinical trial demonstrating the great promise of a completely new type of cancer treatment. The results are announced today in The New England Journal of Medicine.
Diagnostics

House Passes Spending Bill; Amendment To Block Removal Of Needle Exchange Funding Ban Defeated

The House on Friday passed a $730.5 billion bill (HR 3293) "to fund health, education and labor programs in fiscal 2010 after narrowly defeating an attempt to strip language that would lift the ban on federal needle exchange programs," in the U.S., CQ Today reports (Wolfe, 7/24). Lawmakers voted 211-218 to reject an amendment by Mark Souder (R-Ind.) that sought to keep the ban in place, the AP/Lewiston Sun Journal reports (Taylor, 7/25). The bill that passed includes a restriction against using federal funds for needle exchanges within 1,000 feet of day care centers, schools, parks, playgrounds, pools and youth centers, the Washington Post reports. Ronald Johnson, deputy executive director of the Washington, D.C.,-based advocacy group AIDS Action, said, "This is the first time in over 20 years that we are on the verge of recognition by the federal government of the proven cost-effectiveness and impact of syringe exchange as a very important tool for prevention of HIV infection and viral hepatitis," adding, "Allowing the local community to use federal funds is very critical to stopping these epidemics" (Fears, 7/25). The bill also drops funding for abstinence-only sex education and "would provide $114 million for a new teenage pregnancy prevention initiative," the Sun Journal article states (7/25). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):